| Literature DB >> 23085652 |
Nicolas J Martin1, Soizic Prado, Gael Lecellier, Olivier P Thomas, Phila Raharivelomanana.
Abstract
The first phytochemical inspection of the Marquesan endemic plant Rauvolfia nukuhivensis led to the isolation and structure characterization of two new indolo[2,3-a]quinolizinium derivatives named nukuhivensium and N₁₂-methyl-nukuhivensium. They feature an aromatic indolo[2,3-a]quinolizinium core, substituted at C-2 by a n-propyl group, which is unusual in this family of alkaloid derivatives. The structure elucidation was performed on the basis of NMR spectroscopy and especially by interpretation of 2D HMBC correlations. A biosynthetic pathway is proposed on the basis of known enzymatic transformations for this family of natural products. These compounds exhibited low antimicrobial activities.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23085652 PMCID: PMC6268674 DOI: 10.3390/molecules171012015
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of natural indolo[2,3-a]quinoliziniums.
1H (500 MHz) and 13C (125 MHz) NMR data for compounds 1 and 2 in CD3OD.
| Position | 1 | 2 | |||
|---|---|---|---|---|---|
| HMBC (H→C) | |||||
| 1 | 8.65, s | 120.5, CH | 13, 3, 6, 12a, 12b | 8.96, s | 121.5, CH |
| 2 | 154.4, C | 154.1, C | |||
| 3 | 7.83, d (7.0) | 124.4, CH | 4, 1, 13 | 7.86, d (7.0) | 123.9, CH |
| 4 | 9.19, d (7.0) | 137.6, CH | 3, 6, 2, 12b | 9.24, d (7.0) | 138.4, CH |
| 6 | 8.84, d (7.0) | 128.1, CH | 7, 7a, 12b, 4 | 8.90, d (7.0) | 128.1, CH |
| 7 | 8.61, d (7.0) | 117.2, CH | 7b, 6, 12a, 12b | 8.66, d (7.0) | 116.8, CH |
| 7a | 125.0, C | 125.6, C | |||
| 7b | 122.5, C | 128.9, C | |||
| 8 | 8.36, d (8.0) | 123.3, CH | 11, 7b, 7a | 8.41, d (8.0) | 122.8, CH |
| 9 | 7.50, dd (8.0; 7.0) | 122.9, CH | 11, 8, 10, 11a, 7b | 7.54, dd (8.0, 7.0) | 123.5, CH |
| 10 | 7.74, dd (8.0; 7.0) | 131.0, CH | 8, 7b | 7.83, dd (8.0, 7.0) | 131.2, CH |
| 11 | 7.84, d (8.0) | 113.6, CH | 9, 7b, 11a | 7.95, d (8.0) | 112.1, CH |
| 11a | 143.3, C | 144.9, C | |||
| 12 | 4.58, s | 34.6, CH3 | |||
| 12a | 131.7, C | 131.4, C | |||
| 12b | 134.3, C | 135.2, C | |||
| 13 | 3.06, t (7.7) | 38.6, CH2 | 14, 15, 2, 1, 3 | 3.09, t (7.7) | 38.7, CH2 |
| 14 | 1.94, tq (7.7; 7.5) | 23.9, CH2 | 15, 13, 2 | 1.93, tq (7.7, 7.5) | 24.4, CH2 |
| 15 | 1.12, t (7.5) | 14.0, CH3 | 14, 13 | 1.12, t (7.5) | 14.0, CH3 |
Figure 2Key COSY (bold) and HMBC (H → C, arrow) correlations for 1.
Scheme 1Biosynthetic hypothesis for 1.
Antimicrobial activities of 1 and 2.
| Compounds | MIC90
| MIC90
| MIC90
| MIC90
|
|---|---|---|---|---|
| 105 | >150 | 100 | >150 | |
| 115 | >150 | 100 | >150 | |
| Tetracycline | 0.5 | 3 | Nt | Nt |
| Econazole | Nt | Nt | 2.60 | 2.20 |
Nt: Non tested.